Ligand-Transformer enables sequence-based drug design by building on the success of the AlphaFold transformer architecture in predicting protein structures. Notably, with this approach disordered proteins can be targeted for drug design.
biorxiv.org/content/10.110…
biorxiv.org/content/10.110…